menu
    • menu

    Company profile for NexImmune

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    NexImmune is an emerging biopharmaceutical company advancing a new generation of immunotherapies based on our proprietary AIM™ technology. This nanotechnology platform, originally developed at Johns Hopkins University, is the foundation for an innovative approach to immunotherapy in which the body’s own immune system is stimulated to orchestrate a targeted T cell response against a disease. Central to the AIM technology ar...
    NexImmune is an emerging biopharmaceutical company advancing a new generation of immunotherapies based on our proprietary AIM™ technology. This nanotechnology platform, originally developed at Johns Hopkins University, is the foundation for an innovative approach to immunotherapy in which the body’s own immune system is stimulated to orchestrate a targeted T cell response against a disease. Central to the AIM technology are artificial Antigen Presenting Cells (aAPC) that present antigens to T cells eliciting a highly targeted therapy driven by the patient’s immune system.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    NexImmuneUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    9119 Gaither Road Gaithersburg, MD 20877
    Telephone
    Telephone
    +301-825-9810
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.neximmune.com/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/neximmune-inc.
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    NexImmune Announces Closing of $3.67 Million Registered Direct Offering
    NexImmune Announces Closing of $3.67 Million Registered Direct Offering

    06 Feb 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2024/02/06/2824768/0/en/NexImmune-Announces-Closing-of-3-67-Million-Registered-Direct-Offering-Priced-At-the-Market-Under-Nasdaq-Rules.html

    GLOBENEWSWIRE
    06 Feb 2024
    Share Share
    NexImmune Announces $3.67 Million Registered Direct Offering
    NexImmune Announces $3.67 Million Registered Direct Offering

    02 Feb 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2024/02/02/2823027/0/en/NexImmune-Announces-3-67-Million-Registered-Direct-Offering-Priced-At-the-Market-Under-Nasdaq-Rules.html

    GLOBENEWSWIRE
    02 Feb 2024
    Share Share
    NexImmune, Yale, and JDRF Extend Research Partnership for Type 1 Diabetes
    NexImmune, Yale, and JDRF Extend Research Partnership for Type 1 Diabetes

    24 Oct 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/10/24/2765592/0/en/NexImmune-Yale-and-JDRF-Extend-Research-Partnership-for-Type-1-Diabetes.html

    GLOBENEWSWIRE
    24 Oct 2023
    Share Share
    NexImmune Announces Presentations at Annual Meeting
    NexImmune Announces Presentations at Annual Meeting

    19 Oct 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/10/19/2763112/0/en/NexImmune-Announces-Presentations-at-The-Society-for-Immunotherapy-of-Cancer-s-38th-Annual-Meeting.html

    GLOBENEWSWIRE
    19 Oct 2023
    Share Share
    NexImmune Announces 1-for-25 Reverse Stock Split
    NexImmune Announces 1-for-25 Reverse Stock Split

    18 Oct 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/10/18/2762610/0/en/NexImmune-Announces-1-for-25-Reverse-Stock-Split.html

    GLOBENEWSWIRE
    18 Oct 2023
    Share Share
    NexImmune to lay off 53% of employees to save money, CFO to step down
    NexImmune to lay off 53% of employees to save money, CFO to step down

    01 Sep 2023

    // Anna Brown #N/A

    https://endpts.com/neximmune-to-lay-off-53-of-employees-to-save-money-cfo-to-step-down/

    Anna Brown #N/A
    01 Sep 2023
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search